悦康药业(688658) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 was ¥1,213,806,795.75, representing an increase of 8.05% compared to the same period last year[7]. - The net profit attributable to shareholders for Q3 2021 was ¥160,603,263.07, reflecting a growth of 31.92% year-over-year[7]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥144,910,173.38, which is an increase of 51.80% compared to the same period last year[11]. - Total operating revenue for the first three quarters of 2021 reached ¥3,345,210,497.61, an increase of 19.3% compared to ¥2,804,915,697.25 in the same period of 2020[33]. - Net profit for the third quarter of 2021 was ¥372,438,690.81, representing a 46.8% increase from ¥253,748,467.60 in the same quarter of 2020[35]. - Earnings per share for the third quarter of 2021 was ¥0.83, compared to ¥0.71 in the same quarter of 2020, reflecting a 16.9% increase[37]. - The company achieved a total comprehensive income of ¥372,438,690.81 for the third quarter of 2021, compared to ¥253,748,467.60 in the same quarter of 2020[37]. Research and Development - The total R&D investment for the year-to-date was ¥152,653,189.60, showing a significant increase of 58.28% year-over-year[11]. - The R&D investment accounted for 3.65% of operating revenue in Q3 2021, up by 0.57 percentage points from the previous year[11]. - Research and development expenses for the first three quarters of 2021 totaled ¥98,871,475.74, an increase of 22.4% from ¥80,746,081.30 in the previous year[33]. Assets and Liabilities - The company's total assets at the end of the reporting period were ¥5,178,815,071.45, a decrease of 5.10% compared to the end of the previous year[11]. - The total current assets as of September 30, 2021, amounted to ¥3,563,101,233.42, a decrease from ¥3,892,108,704.98 as of December 31, 2020, representing a decline of approximately 8.43%[24]. - The company's cash and cash equivalents were reported at ¥2,235,683,085.51, down from ¥2,534,922,501.23, indicating a decrease of about 11.8%[24]. - Total liabilities as of September 30, 2021, were ¥1,422,981,872.35, down from ¥1,871,102,363.29, indicating a decrease of approximately 24%[31]. - The company's total assets were reported at ¥5,178,815,071.45, a decline from ¥5,456,996,871.58, representing a decrease of about 5.09%[24]. - The total non-current assets increased to ¥1,615,713,838.03 from ¥1,564,888,166.60, reflecting an increase of approximately 3.23%[28]. - The company reported a short-term loan of ¥9,009,625.00, significantly reduced from ¥160,240,356.94, indicating a decrease of approximately 94.39%[31]. - Total liabilities amounted to $1,871,102,363.29, a decrease from $1,886,994,228.55, reflecting a reduction of $15,891,865.26[53]. Cash Flow - The company reported a net cash flow from operating activities of ¥284,815,436.92 for the year-to-date, which is a slight increase of 1.65% year-over-year[11]. - Cash flow from operating activities for the first three quarters of 2021 was ¥284,815,436.92, slightly up from ¥280,204,620.16 in the same period of 2020[41]. - The net cash flow from investment activities was -173,851,973.15 RMB, a decrease compared to -131,106,460.90 RMB in the previous period[45]. - The cash outflow from financing activities was 415,303,099.54 RMB, compared to 414,298,366.74 RMB in the previous period[45]. - The company reported a cash flow from financing activities net amount of -406,303,099.54 RMB, worsening from -219,267,520.70 RMB previously[45]. Equity - The equity attributable to shareholders at the end of the reporting period was ¥3,751,967,858.05, which is an increase of 4.78% year-over-year[11]. - Total equity attributable to shareholders reached $3,580,924,323.01, remaining stable compared to the previous period[53]. - The total equity, including minority interests, was $3,585,894,508.29, unchanged from prior reports[53]. - The capital reserve remained at $2,645,177,299.84, indicating no change[53]. Compliance and Standards - The company adopted the new leasing standards effective January 1, 2021, which did not significantly impact its financial position, operating results, or cash flows[53]. - The company’s financial statements reflect compliance with the revised accounting standards as mandated by the Ministry of Finance[53]. - The company’s financial adjustments due to the new leasing standards were based on the present value of lease liabilities discounted at incremental borrowing rates[53].